Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Albany Molecular Research Inc. (AMRI)

-NasdaqGS
16.09 Up 0.02(0.12%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 67,122   60,755   59,292   59,406  
Cost of Revenue47,103  44,548  42,450  37,822  
Gross Profit 20,019   16,207   16,842   21,584  
Operating Expenses
Research Development44  94  171  105  
Selling General and Administrative11,517  9,820  13,023  10,663  
Non Recurring1,492  276  5,859  1,413  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 6,966   6,017   (2,211) 9,403  
Income from Continuing Operations
Total Other Income/Expenses Net(88)98  321  452  
Earnings Before Interest And Taxes6,878  6,115  (1,890)9,855  
Interest Expense1,011  81  81  82  
Income Before Tax5,867  6,034  (1,971)9,773  
Income Tax Expense1,375  2,104  276  3,268  
Minority Interest -   -   -   -  
Net Income From Continuing Ops4,492  3,930  (2,247)6,505  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 4,492   3,930   (2,247) 6,505  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 4,492   3,930   (2,247) 6,505  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.